The MoHAP approval underscores SIBIONICS' commitment to delivering cutting-edge CGM technologies that meet rigorous safety and efficacy standards. This fingerstick-free, factory-calibrated, and ...

SHENZHEN, China, Nov. 1, 2023 /CNW/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring System (CGM) brand, is delighted to announce that it has received the CE Mark for its ...

SHENZHEN, China, Oct. 2, 2023 /PRNewswire/ -- The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, ...

Sibionics Technology Co. Ltd. said it received the CE mark for its continuous glucose monitoring (CGM) system, coined the Sibionics GS1 CGM, helping the company expand its market opportunities beyond ...

BARCELONA, Spain, March 14, 2026 /PRNewswire/ -- At the ATTD 2026, AI has become one of the most discussed topics in the future of diabetes care. As CGM becomes widely adopted, the next challenge is ...

SHENZHEN, China, July 25, 2024 /PRNewswire/ -- SIBIONICS, a leading innovator in continuous glucose monitoring technology, announced today that it has received Product Marketing Authorization Approval ...